All Stories

  1. Microsampling for antidepressant drug analysis: Current state and perspectives
  2. In Memoriam: Professor Minyong Li (1976–2025)
  3. Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent
  4. Transformational Goal for Science Education: The 1Student - 1Apparatus (1S1A) Model
  5. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation
  6. Optimizing Target Metabolites Production in Coleus blumei Indoor Cultivation: Combined Effects of LED Light and Salinity Stress
  7. Influence of Various Fruit Preservation Methods on the Phenolic Composition and Antioxidant Activity of Prunus spinosa L. Fruit Extract
  8. Development of a MS compatible HPLC-HILIC method for the analysis of allantoin and glycolic acid in snail slime and related dosage forms: Focus on the enantioseparation of allantoin
  9. Volumetric absorptive microsampling for in vitro metabolism of the recent synthetic cannabinoid receptor agonist 5F-PB-22
  10. Editorial Board Translational Chemistry 2025
  11. Bioengineered Indoor Farming Approaches: LED Light Spectra and Biostimulants for Enhancing Vindoline and Catharanthine Production in Catharanthus roseus
  12. Novel microsampling approach using fabric-phase sorptive extraction (FPSE) for cannabinoid analysis in blood
  13. Review: the role of automation in improving the performance and throughput of microsample bioanalysis
  14. GinExtraMed: Focus on Rosa canina L. Extract Encapsulated into Glycethosomes and Allanthosomes for Accelerating Skin Wound Healing
  15. Quantitative urine spot microsamples for the chiral analysis of clenbuterol by capillary electrokinetic chromatography
  16. A Cost‐Effective Nonaqueous Reversed‐Phase High‐Performance Liquid Chromatography Method to Measure Vitamin D3 in Hen's Egg Yolk
  17. Normalization methods in mass spectrometry-based analytical proteomics: A case study based on renal cell carcinoma datasets
  18. Characterisation and Quantification of Phenolic Compounds in Honeys from Sierra Nevada (Granada)
  19. Evaluation of the Antioxidant Capacity of Fruit Juices by Two Original Analytical Methods
  20. Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography
  21. A Complex Methodological Approach for the Screening of Efficient and Safe Cobalt Chelators
  22. Natural Products for the Prevention and Treatment of Common Cold and Viral Respiratory Infections
  23. Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
  24. Oral D-Aspartate Treatment Improves Sperm Fertility in Both Young and Adult B6N Mice
  25. Extraction, Encapsulation into Lipid Vesicular Systems, and Biological Activity of Rosa canina L. Bioactive Compounds for Dermocosmetic Use
  26. Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5
  27. Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide
  28. Treatment of Benign Prostatic Hyperplasia by Natural Drugs
  29. Separation and non-separation methods for the analysis of cannabinoids in Cannabis sativa L.
  30. Enhanced urinary stability of peptide hormones and growth factors by dried urine microsampling
  31. Discriminating different Cannabis sativa L. chemotypes using attenuated total reflectance - infrared (ATR-FTIR) spectroscopy: A proof of concept
  32. Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
  33. VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS
  34. Optimized Extraction of Amikacin from Murine Whole Blood
  35. Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics
  36. Development of an electrochemical sensor based on carbon black for the detection of cannabidiol in vegetable extracts
  37. α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis
  38. Improved Achiral and Chiral HPLC-UV Analysis of Ruxolitinib in Two Different Drug Formulations
  39. Dried Urine Microsampling Coupled to Liquid Chromatography—Tandem Mass Spectrometry (LC–MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids
  40. Microsampling and LC–MS/MS for antidoping testing of glucocorticoids in urine
  41. Thymus vulgaris L. Essential Oil Solid Formulation: Chemical Profile and Spasmolytic and Antimicrobial Effects
  42. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  43. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  44. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  45. Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest
  46. Duloxetine plasma level and antidepressant response
  47. Cannabinoids from Cannabis sativa L.: A New Tool Based on HPLC–DAD–MS/MS for a Rational Use in Medicinal Chemistry
  48. Perspectives and strategies for anti-doping analysis
  49. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
  50. Effects of oral d-aspartate on sperm quality in B6N mice
  51. Feedback from the fourth European Bioanalysis Forum Young Scientist Symposium
  52. Encapsulations of wild garlic (Allium ursinum L.) extract using spray congealing technology
  53. Tutorial: Volumetric absorptive microsampling (VAMS)
  54. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  55. A simple, cheap but reliable method for evaluation of zinc chelating properties
  56. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  57. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  58. Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti- Candida agent
  59. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  60. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  61. Increased oxytocin levels among abstinent heroin addicts: Association with aggressiveness, psychiatric symptoms and perceived childhood neglect
  62. Dried haematic microsamples and LC–MS/MS for the analysis of natural and synthetic cannabinoids
  63. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis
  64. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  65. Phytochemical analysis and antibacterial activity towards methicillin-resistant Staphylococcus aureus of leaf extracts from Argania spinosa (L.) Skeels
  66. LC–MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples
  67. Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices
  68. Analytical Profiling of Bioactive Phenolic Compounds in Argan (Argania spinosa ) Leaves by Combined Microextraction by Packed Sorbent (MEPS) and LC-DAD-MS/MS
  69. Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs
  70. TDM of novel antipsychotics
  71. Bioactive molecules as authenticity markers of Italian Chinotto (Citrus×myrtifolia) fruits and beverages
  72. Microextraction by packed sorbent (MEPS) to analyze catecholamines in innovative biological samples
  73. Discontinued anxiolytic drugs (2009 – 2014)
  74. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  75. Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent
  76. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  77.  9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood
  78. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  79. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  80. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  81. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  82. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  83. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  84. Validation of a dried blood spot LC–MS/MS approach for cyclosporin A in cat blood: Comparison with a classical sample preparation
  85. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  86. Ketoconazole-Associated Preferential Increase in Dopamine D2 Receptor Occupancy in Striatum Compared to Pituitary In Vivo
  87. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  88. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  89. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  90. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  91. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  92. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  93. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  94. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  95. Analysis of Aloe-based phytotherapeutic products by using nano-LC-MS
  96. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  97. Enhanced expression of the neuronal K+/Cl− cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats
  98. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  99. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  100. Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure
  101. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  102. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  103. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines
  104. Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection
  105. Benzodiazepine Metabolism: An Analytical Perspective
  106. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  107. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  108. HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma
  109. Comparison of analytical methods for the quality control of a new formulation containing soy extract and melatonin
  110. Determination of plasma and urine levels of Δ9-tetrahydrocannabinol and its main metabolite by liquid chromatography after solid-phase extraction
  111. HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure
  112. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  113. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  114. Determination of sertraline andN-desmethylsertraline in human plasma by CE with LIF detection
  115. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  116. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma
  117. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  118. Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction
  119. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography
  120. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  121. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  122. Erratum
  123. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients